Skip to main content

Go Premium in Our Biggest Sale Ever

UPGRADE NOW
TipRanks
Go Ultimate75% OFF

Great Novel Therapeutics Biotech & Medicals Corp. (7427) Income Statement

Great Novel Therapeutics Biotech & Medicals Corp. Income Statement

Last quarter (Q2 2026), Great Novel Therapeutics Biotech & Medicals Corp.'s total revenue was NT$5.63M, an increase of 967.55% from the same quarter last year. In Q2, Great Novel Therapeutics Biotech & Medicals Corp.'s net income was NT$-58.98M. See Great Novel Therapeutics Biotech & Medicals Corp.’s key income statements, including revenue, expenses, profit, and income.

Income Statement
Income StatementDec 25Dec 24Dec 23Dec 22Dec 21
NT$ 1.21MNT$ 1.69MNT$ 4.85MNT$ 540.00KNT$ 630.00K
NT$ -8.87MNT$ 1.01MNT$ 4.81MNT$ 464.00KNT$ 283.00K
NT$ 90.68MNT$ 113.66MNT$ 70.63MNT$ 57.90MNT$ 36.80M
Depreciation and AmortizationNT$ 7.68MNT$ 6.94MNT$ 4.34MNT$ 1.82MNT$ 1.50M
NT$ -91.86MNT$ -97.86MNT$ -57.11MNT$ -53.96MNT$ -35.08M
NT$ -99.54MNT$ -112.65MNT$ -65.82MNT$ -57.44MNT$ -36.52M
NT$ 2.07MNT$ 7.72MNT$ 4.82MNT$ 1.66MNT$ 664.00K
NT$ -97.47MNT$ -104.92MNT$ -61.54MNT$ -55.78MNT$ -35.86M
NT$ -97.47MNT$ -104.92MNT$ -61.54MNT$ -55.78MNT$ -35.86M
Per Share Metrics
Basic EPSNT$ -2.15NT$ -2.55NT$ -1.70NT$ -2.31NT$ -1.70
Diluted EPSNT$ -2.15NT$ -2.55NT$ -1.70NT$ -2.31NT$ -1.70
Weighted Average Shares Outstanding45.33M41.22M36.28M24.15M21.09M
Weighted Average Shares Outstanding (Diluted)45.33M41.22M36.28M24.15M21.09M

Currency in TWD

Great Novel Therapeutics Biotech & Medicals Corp. Earnings and Revenue History

-120M-60M060M-450000 %-300000 %-150000 %0 %EarningsProfit Margin201720182019202020212022202320242025RevenueEarningsProfit Margin